Literature DB >> 11750237

Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies.

Julia A Knight1, Heather J Sutherland, Gordon Glendon, Norman F Boyd, Irene L Andrulis.   

Abstract

PURPOSE: The Ontario site of the Cooperative Family Registry for Breast Cancer Studies collects cancer family history, other risk factor information, and biospecimens from individuals with incident breast cancer and their relatives within a defined population. Sampling is based on age and defined genetic risk criteria. The purpose of this analysis was to evaluate the representativeness of the respondents.
METHODS: We examined characteristics associated with response to requests for information, biospecimens, and permission to contact relatives among those diagnosed with breast cancer in 1996 in the province of Ontario.
RESULTS: Overall, response was good among the largest group, white women, and did not differ between those with and without a family history of breast and/or ovarian cancer. Women who described themselves as other than white and men tended to have lower response. Women of Ashkenazi heritage had high response except for permission to contact relatives.
CONCLUSIONS: There was no evidence that participation in a familial breast cancer registry derived from a population-based cancer registry was influenced by having a family history of breast or ovarian cancer. The use of a cancer registry approach is likely more representative of the population than clinic-based recruitment of families for genetic studies.

Entities:  

Mesh:

Year:  2002        PMID: 11750237     DOI: 10.1016/s1047-2797(01)00253-8

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  18 in total

1.  Joint replacement recipients' views about health information privacy.

Authors:  Amanda L Terry; Bert M Chesworth; Robert B Bourne; Paul Stolee; Mark Speechley
Journal:  Health Expect       Date:  2013-10-01       Impact factor: 3.377

2.  Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival.

Authors:  Marcelo Sobral-Leite; Koen Van de Vijver; Magali Michaut; Rianne van der Linden; Gerrit K J Hooijer; Hugo M Horlings; Tesa M Severson; Anna Marie Mulligan; Nayana Weerasooriya; Joyce Sanders; Annuska M Glas; Diederik Wehkamp; Lorenza Mittempergher; Kelly Kersten; Ashley Cimino-Mathews; Dennis Peters; Erik Hooijberg; Annegien Broeks; Marc J van de Vijver; Rene Bernards; Irene L Andrulis; Marleen Kok; Karin E de Visser; Marjanka K Schmidt
Journal:  Oncoimmunology       Date:  2018-09-11       Impact factor: 8.110

3.  Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.

Authors:  Michael A Campitelli; Anna M Chiarelli; Lucia Mirea; Lindsay Stewart; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

4.  The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry.

Authors:  Roger L Milne; Esther M John; Julia A Knight; Gillian S Dite; Melissa C Southey; Graham G Giles; Carmel Apicella; Dee W West; Irene L Andrulis; Alice S Whittemore; John L Hopper
Journal:  Int J Epidemiol       Date:  2011-07-19       Impact factor: 7.196

5.  Fresh Cut Versus Stored Cut Paraffin-embedded Tissue: Effect on Immunohistochemical Staining for Common Breast Cancer Markers.

Authors:  Catherine L Forse; Dushanthi Pinnaduwage; Shelley B Bull; Anna Marie Mulligan; Irene L Andrulis
Journal:  Appl Immunohistochem Mol Morphol       Date:  2019-03

6.  Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

7.  Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors.

Authors:  Sherry L Winter; Lucine Bosnoyan-Collins; Dushanthi Pinnaduwage; Irene L Andrulis
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

8.  Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk.

Authors:  Sean P Cleary; Hyeja Kim; Marina E Croitoru; Mark Redston; Julia A Knight; Steven Gallinger; Robert Gryfe
Journal:  Dis Colon Rectum       Date:  2008-07-10       Impact factor: 4.585

9.  Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.

Authors:  Ellen T Chang; Roger L Milne; Kelly-Anne Phillips; Jane C Figueiredo; Meera Sangaramoorthy; Theresa H M Keegan; Irene L Andrulis; John L Hopper; Pamela J Goodwin; Frances P O'Malley; Nayana Weerasooriya; Carmel Apicella; Melissa C Southey; Michael L Friedlander; Graham G Giles; Alice S Whittemore; Dee W West; Esther M John
Journal:  Breast Cancer Res Treat       Date:  2008-11-26       Impact factor: 4.872

10.  Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry.

Authors:  Meghan J Walker; Lucia Mirea; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight; Anna M Chiarelli
Journal:  Breast       Date:  2014-05-10       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.